THCP (Tetrahydrocannabiphorol)

Editor's note: THCP is not a terpene

The brief for this article asked for a terpene write-up, but THCP — tetrahydrocannabiphorol — is a phytocannabinoid, structurally related to THC. It belongs to the same chemical family as Δ9-THC, CBD, CBG, and CBN, not to monoterpenes like myrcene or sesquiterpenes like caryophyllene. We've kept the cannabinoid framing throughout because writing it as a terpene would be factually wrong. Strong evidence

What THCP is

THCP is a naturally occurring analog of Δ9-tetrahydrocannabinol with a seven-carbon (n-heptyl) alkyl side chain instead of THC's five-carbon (n-pentyl) chain. It was first isolated and characterized by Citti and colleagues in 2019 from the Italian medicinal cannabis variety FM2, and reported in Scientific Reports ^[1]. Strong evidence

The length of that side chain matters. Structure-activity work going back decades shows that CB1 receptor binding affinity in the THC series increases as the alkyl chain lengthens, peaking around 7–8 carbons ^[2]. THCP sits near that optimum, which is why its in-vitro CB1 affinity (Ki ≈ 1.2 nM) is roughly 33× higher than Δ9-THC's in the same assay ^[1]. Strong evidence

A matching cannabidiol analog, CBDP, was identified in the same study ^[1].

Where it's found in cannabis

In the original 2019 report, THCP was detected in the FM2 chemovar at roughly 0.0029% by dry weight — about a thousandth the concentration of Δ9-THC in the same sample ^[1]. Subsequent analytical surveys have detected it in other chemovars at similarly trace levels ^[3]. Strong evidence

This matters commercially. Almost no plant on the market naturally contains psychoactively relevant amounts of THCP. Products sold today as 'THCP gummies,' 'THCP vapes,' or 'THCP flower' are overwhelmingly made by semi-synthetic conversion from hemp-derived CBD, not by extraction from high-THCP plants. The purity, isomeric composition, and byproduct profile of those products are not well-characterized in peer-reviewed literature. Weak / limited

Aroma and sensory profile

THCP, like THC, is essentially odorless and tasteless at the concentrations present in cannabis. Cannabinoids are not the source of cannabis aroma — that job belongs to terpenes and, to a smaller extent, volatile sulfur compounds. Strong evidence

If someone tells you a flower 'smells like THCP,' they are describing the terpene profile of that flower, not the cannabinoid.

Effects research: what we actually know

In vitro (test tube): THCP binds the human CB1 receptor with about 33× the affinity of Δ9-THC, and CB2 with about 5–10× the affinity ^[1]. Strong evidence

In mice: Citti et al. ran the standard mouse 'tetrad' assay (hypomotility, analgesia, catalepsy, hypothermia) used to screen cannabinoids. THCP produced THC-like effects at lower doses than THC in some tetrad measures, consistent with higher potency, though not by a clean 33× factor ^[1]. Weak / limited

In humans: There are no published controlled human pharmacokinetic or pharmacodynamic studies of isolated THCP at the time of writing. Claims that THCP is '10×' or '33× stronger than THC' in users are extrapolations from a receptor-binding number, not measurements of subjective effect, intoxication, or duration. Receptor affinity is one input into a drug's real-world potency; absorption, distribution, metabolism, partial-vs-full agonism, and tolerance all matter too. No data

Safety: No clinical safety data exist for isolated THCP. Adverse-event reports tied to consumer THCP products are confounded by the semi-synthetic manufacturing route and likely co-presence of isomers and reaction byproducts ^[4]. Weak / limited

Strains 'high in THCP'

Honestly: there aren't any, in the sense that 'high in myrcene' is meaningful for a terpene. Published analyses find THCP at trace levels (parts per million range) across the chemovars tested, including the Italian medicinal variety FM2 where it was first found ^[1][3]. Strong evidence

Marketing copy that labels specific cultivars as 'THCP strains' is not supported by routine certificates of analysis, which generally do not even test for THCP. If you see a product claiming a specific THCP percentage in flower (e.g. '2% THCP'), that claim is extraordinary and should be backed by a third-party COA from an accredited lab — and even then, verify the method. Disputed

Related cannabinoids (not terpenes)

Because THCP is a cannabinoid, the meaningful comparisons are to other phytocannabinoids, not to terpenes:

• Δ9-THC — the five-carbon parent compound; the cannabinoid THCP is most often compared to.
• THCV (tetrahydrocannabivarin) — three-carbon side chain; lower CB1 affinity, different effect profile.
• CBDP (cannabidiphorol) — the CBD analog with the same seven-carbon chain, co-discovered with THCP ^[1].
• Δ8-THC and HHC — other minor or semi-synthetic cannabinoids commonly sold alongside THCP in unregulated markets.

If you came here looking for terpene relationships, see myrcene, limonene, and caryophyllene instead.

Bottom line

THCP is a real, peer-reviewed discovery with interesting pharmacology and almost no human data. The receptor-binding result is solid; the marketing leap from 'binds CB1 33× tighter' to 'gets you 33× higher' is not. Until controlled human studies exist, treat consumer THCP products as poorly characterized semi-synthetics and dose conservatively, if at all. Weak / limited

Sources

How this page was made